Herbert L. Ley
Army Medical Department
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Herbert L. Ley.
Annals of Internal Medicine | 1948
Theodore E. Woodward; Joseph E. Smadel; Herbert L. Ley; Richard Green; D.S. Mankikar
Excerpt A new antibiotic Chloromycetin has been clinically tested in the treatment of typhoid fever and has been found to exhibit significant chemotherapeutic effects. A description of the results ...
Annals of Internal Medicine | 1951
Joseph E. Smadel; Herbert L. Ley; Fred H. Diercks
Excerpt Chloramphenicol now has an established place in the treatment of typhoid fever.1, 2, 3, 4, 5However, it has been our observation, as well as that of others, that little if any clinical impr...
Experimental Biology and Medicine | 1948
Herbert L. Ley; Joseph E. Smadel; Thomas T. Crocker
Conclusion These limited trials indicate that Chloromycetin can be given orally to normal adult males in single doses of 2.0 g, or in daily doses of 1.0 g for 10 days without untoward reactions. The presence of appreciable amounts of drug in the blood and urine of volunteers 30 minutes after oral administration of Chloromycetin indicates that the antibiotic is absorbed rapidly from the gastrointestinal tract of man. Excretion or inactivation of the drug occurs rather rapidly, hence, in order to maintain appreciable levels of the antibiotic in the blood, frequent administration of the drug is indicated.
Experimental Biology and Medicine | 1948
Joseph E. Smadel; Albert P. León; Herbert L. Ley; Gerardo Várela
Conclusion On the basis of these limited observations, it may be concluded that the administration of Chloromycetin to patients with typhus fever is a relatively safe procedure. Furthermore, the chemotherapeutic effect obtained in the few patients treated was sufficiently encouraging to warrant further tests with the drug. It is suggested that Chloromycetin be employed in oral treatment of the next group of patients to be studied according to the following schedule; an initial dose of 40 mg per kilo body weight followed by a total daily dose of 35 mg per kilo body weight, given in divided amounts at 2-hour intervals, until obvious improvement in the patients condition is noted; subsequently maintenance dose of 20 mg per kilo body weight per day given in divided amounts at 4-hour intervals, until the 13 th or 14th day after onset.
Experimental Biology and Medicine | 1949
Joseph E. Smadel; Elizabeth B. Jackson; Herbert L. Ley; Raymond Lewthwaite
Conclusion Chloromycetin prepared by chemical synthesis appears to possess the same rickettsiostatic and virustatic properties in experimental infections and the same usefulness in treating patients with scrub typhus that have been demonstrated for chloromycetin produced by Streptomyces venezuelae, N. Sp.
Wilderness & Environmental Medicine | 2004
Theodore E. Woodward; Joseph E. Smadel; Herbert L. Ley; Richard Green; D.S. Mankikar
Chloromycetin is a crystalline substance obtained through processes of concentration and purification of culture in liquid media of a Streptomyces sp. originally isolated by Burkholder,† and shown by him to possess anti-bacterial activity. Erlich and associates1 in the Research Laboratories of Parke, Davis and Company carried out studies of the antibiotic activity of this Streptomyces which led to preparation of the crystalline antibiotic compound to which Erlich gave the name Chloromycetin. Chloromycetin is a neutral compound containing both nitrogen and nonionic chlorine. In distilled water it withstands boiling for five hours, and in aqueous solutions over the pH range 2 to 9 is unaffected by standing at room temperature for more than 24 hours. Its solubility in water at 25 C. is about 2.5 mg./ml. and it is reported as very soluble in propylene glycol, methanol, ethanol, butanol and acetone. It is well absorbed from the gastrointestinal tract. Serum levels of the drug after oral administration have been found to be comparable to those obtained by parenteral injection. Present evidence indicates that the antibiotic is fairly rapidly excreted or inactivated. Reported toxicity experiments on animals2 indicate that when
Science | 1948
Joseph E. Smadel; Theodore E. Woodward; Herbert L. Ley; Cornelius B. Philip; Robert Traub; B. Lewthwaite; S. R. Savoor
American Journal of Epidemiology | 1952
Joseph E. Smadel; Herbert L. Ley; Fred H. Diercks; J. A. P. Cameron
American Journal of Epidemiology | 1949
Joseph E. Smadel; Robert Traub; Herbert L. Ley; Cornelius B. Philip; Theodore E. Woodward; Raymond Lewthwaite
American Journal of Epidemiology | 1951
Joseph E. Smadel; Herbert L. Ley; Fred H. Diercks; Robert Traub; Vernon J. Tipton; Lyman P. Frick